The patient login page on IntakeQ for the online weight-loss telehealth brand Club Compound; Club Compound connects patients with licensed doctors who prescribe compounded GLP-1 (tirzepatide, semaglutide) and ships the medication to their door.
This subdomain is not a standalone product but the patient portal and intake forms hosted on IntakeQ for the Texas online weight-loss telehealth brand Fifty 410 (fifty410.com, founded in 2023, Dallas/Prosper TX). Fifty 410 caught the 2022–2025 semaglutide/tirzepatide shortage and the window in which the FDA allowed pharmacies to compound them, entering with "cash-pay compounded GLP-1 online prescriptions at $133–199/month". It registered the domain in 2023-10, launched in 2023-11, opened Facebook/Instagram/TikTok in 2024, and built up 6,500+ reviews at 4.8 on Trustpilot by actively inviting reviews, claiming to have served 200K+ patients. The portal subdomain's traffic is almost all existing patients coming back to fill out forms for refills (direct 80%, email 15%); it does not acquire customers itself.One-line growth story, compiled by us from public sources; speculation is marked separately below.
The main engine is repeat purchases from existing patients: this is the patient portal that the weight loss brand Fifty 410 hosts on IntakeQ, and existing patients have to come back to log in and fill out an intake form every time they renew a prescription. Direct visits are 80%, and email is second.
The lubricant is email and good reviews: email pulls existing patients back to the portal, and the parent site actively solicited reviews, building up 6,567 Trustpilot reviews at 4.8 stars to vouch for new patients.
By our estimate, over 80% of visits are existing patients coming back to renew a prescription and fill out a form; about 5.2 of every 100 visits click through to the checkout page.
Model: Lenny's racing growth framework. This subdomain is the patient portal and intake form that the weight loss telehealth brand Fifty 410 hosts on IntakeQ, and it does not acquire customers itself: engine = repeat purchases from existing patients (they have to come back to log in and fill out a form every time they renew); lubricant = email pulling existing patients back to the portal, and Trustpilot good reviews vouching for new patients. How the parent site acquires customers was not found; it is presumed to be Meta ads and Instagram content.
Real data: 63,900 visits, -40.51% month over month, largest channel direct at 80.45%, top-three channel ranking (direct, email, organic social), social source Facebook, only the US listed as a country, bounce rate 34.22%, 4.34 pages per visit, average stay 4 minutes 51 seconds, all from the Similarweb public page for last month; the public page does not give the shares of the second and third channels, and does not list search keywords or referring sites. 3,316 visits (about 3,300) to the Stripe checkout page come from quietmoney checkout page data.
Supporting evidence: The Patient Portal link in the fifty410.com footer points to fifty410.intakeq.com/portal. Fifty 410 was founded in 2023 and is headquartered in Dallas, Texas, with 11-50 employees on LinkedIn; the official site says it has served 200,000+ patients, with GLP-1 plans from $133-199/month; Trustpilot shows 4.8 stars and 6,567 reviews, which the company actively solicited; Instagram has about 45,000 followers. It caught the window created by the semaglutide and tirzepatide shortages and pharmacy compounding being allowed. One place in the profile described this subdomain as a Club Compound login page, which was corrected to Fifty 410 after a follow-up check.
Inference: The two channel circles are real; how each is split is an inference: direct 51,400 = existing patients coming back to renew 45,000 + new patients getting the portal link to fill out the form 4,400 + seeing social posts and reviews 2,000; other channels 12,500 = existing patients clicking email to come back 8,500 + new patients 2,500 + seeing Facebook posts 1,500. The profile also recorded an older set of figures (email 14.7%, social 2.9%), used only to judge that email is the larger part of the second circle, not as real shares. The ratios of 50% filling out the form after new patients get the link and 2% visiting after seeing social media are guesses; the 40% drop in visits month over month may be related to tighter regulation of compounded GLP-1 and switching pharmacies, which is also an inference.
Checkout: buy.stripe.com
“login form only; "Don't have an account?"; hello@clubcompound.com”Quote from the site
New-user source: Other (Direct / referral / email / paid). Almost no customer acquisition: direct 80.5%, email 14.7%, which is existing patients coming back to log in and fill out forms; social 2.9% from Facebook. Peak of 13,950 two months ago, 3,316 last month
Top channel measured by Similarweb, others estimated by rank
| Attributable new users, last month | Share |
|---|---|
| 3% | |
| Other | 97% |
Direct + brand search 80%. Direct and brand search count as viral only when the site shows sharing mechanics; the largest share wins, under 5% means Other.
| Country | Share of visits |
|---|---|
| United States | 57.67% |
English
About 3,316 last month (Similarweb estimate), #589 of 606; the month before was 13,950. Opening checkout is not paying, so this is not revenue.
New-user source: Other (Direct / referral / email / paid). Mostly referrals, email or paid, or mostly direct with no clear source Almost no customer acquisition: direct 80.5%, email 14.7%, which is existing patients coming back to log in and fill out forms; social 2.9% from Facebook. Peak of 13,950 two months ago, 3,316 last month
Club Compound site: tirzepatide 3-month plan $399–699, 6-month $899–1,099; semaglutide $399–1,149 (the $29.90–84.90/month in the input is the price of the IntakeQ software itself, not this site)
Dossier confidence: medium. Parts 1 and 2 come from reading the site and Similarweb data; part 3 from public reporting, founder posts, Wayback snapshots, WHOIS and similar, with speculation marked.
The number: checkout visits is Similarweb's estimate of visits from the site to a checkout payment page; opening checkout is not paying, so this is not revenue. Small sites land on fixed buckets.
Data through last month. Page updated 2026-10-31.